VB10.16

About Nykode Therapeutics

Nykode Therapeutics is a clinical-stage biopharma company leveraging its proprietary Vaccibody™ platform to develop targeted immunotherapies for cancer and autoimmune diseases. Founded on foundational research from the University of Oslo, the company has achieved key milestones including uplisting to the Oslo Stock Exchange and establishing high-value partnerships with Roche and Regeneron. Its strategy focuses on accelerating its internal pipeline, expanding the platform into new therapeutic areas, and forging selective strategic partnerships to maximize commercial potential.

Therapeutic Areas